TORRENT PHARMACEUTICALS LTD. - 500420 - Intimation Regarding Transfer Of Shares Of The Company Pursuant To SEBI Circular No. SEBI/H0/MIRSD/DOS3/CIR/P/2018/139 Dated November 6, 2018 On "Standardized Norms For Transfer Of Securities In Physical Mode
Intimation regarding transfer of shares of the Company pursuant to SEBI Circular No. SEBI/H0/MIRSD/DOS3/CIR/P/2018/139 dated November 6, 2018 on "Standardized norms for transfer of securities in physical mode TORRENT PHARMACEUTICALS LTD. - 500420 - Redemption Of Commercial Paper
Pursuant to Regulation 30 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Commercial Paper of Rs. 100 Crores (Rupees One Hundred Crores) issued on 17th May, 2019 has been fully redeemed and repaid on maturity date i.e. 23rd September, 2019. Torrent Pharma expands recall of hypertension drug in US
Expanding recall for Losartan potassium tablets USP and Losartan potassium / hydrochlorothiazide tablets to the consumer level Torrent Pharmaceuticals Ltd - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificate TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Issue of Securities
Intimation regarding issue of Non-Convertible Debentures on Private Placement basis TORRENT PHARMACEUTICALS LTD. - 500420 - Redemption Of Commercial Paper
Pursuant to Regulation 30 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Commercial Paper of Rs. 200 Crores (Rupees Two Hundred Crores) issued on 03rd May, 2019 has been fully redeemed and repaid on maturity date i.e. 16th September, 2019. Kindly take note of the above. Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Credit Rating
Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, it is hereby informed that the Company has received the Credit Rating of 'IND AA/Stable' by India Ratings and Research Private Limited for the proposed issue of Non-Convertible Debentures of Rs 300 crores. This is for your information and record. TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificate TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Issue of Duplicate Share Certificate TORRENT PHARMACEUTICALS LTD. - 500420 - Newspaper Advertisement Pursuant To SEBI Circular No SEBI/HO/MIRSD/DOS3/CIR/P/2018/139 Dated 6Th November, 2018
In reference to captioned subject, we enclose herewith the copies of the newspaper advertisement published in 'The Financial Express' (English and Gujarati) on 21-Aug-19 pursuant to the request received by the Company for transfer of shares under SEBI circular no SEBI/HO/MIRSD/DOS3/CIR/P/2018/139 dated 6th November, 2018 ('Circular'). If no claim / objection has been received by the Registrar and Transfer Agent of the Company M/s Karvy Fintech Private Limited with respect to the said transfer within 30 days from the date of the publication of the advertisement, the Company will proceed with the transfer of shares as per the provisions of the Circular